ACIU — AC Immune AG Share News
0.000.00%
Last trade - 00:00- $249.35m
- $163.15m
- CH₣3.57m
U.S. STOCKS ON THE MOVE-TD Synnex, Nucor, Pfizer
U.S. STOCKS ON THE MOVE-Xerox, AC Immune, OpGen
AC Immune rises as Alzheimer's vaccine shows promise in early-stage study
Brief: Ac Immune Partner Life Molecular Imaging Initiates Phase 3 Study For Alzheimer’S Disease Drug
U.S. STOCKS ON THE MOVE-Viridian, Carvana, Titan Machinery
U.S. STOCKS ON THE MOVE-3M Co, copper miners, Build-A-Bear Workshop
U.S. STOCKS ON THE MOVE-Crypto stocks, gold miners, Horizon Therapeutics
AC Immune rises as Alzheimer vaccine set for development
Brief: Ac Immune’S Alzheimer’S Disease Vaccine-Candidate Selected For Further Development
Brief: Ac Immune To Present Progress Of Alzheimer’S Disease Programs Targeting Abeta And Tau At The 15Th Ctad Conference
Factbox: Roche's drug failure extends long list of Alzheimer's trial setbacks
Brief: AC Immune SA Reports Q3 Loss Per Share Of CHF 0.16
Factbox: Eisai-Biogen Alzheimer's drug success follows many failures
Factbox: Eisai-Biogen Alzheimer's drug success follows many failures
Brief: Ac Immune Partner LMI Progresses Tau PET Tracer PI-2620 Into Late-Stage Development In Alzheimer’S Disease
Brief: AC Immune Receives Grant From Michael J Fox Foundation
Brief: AC Immune To Present Data From Phase II Crenezumab Alzheimer’s Prevention Initiative Study
Brief: Ac Immune Reports Q2 2022 Financial Results
Swiss stocks - Factors to watch on June 24